Block and Graft Copolymers and Nanogel™ Copolymer Networks for DNA Delivery into Cell

Abstract

Self-assembling complexes from nucleic acids and synthetic polymers are evaluated for plasmid and oligonucleotide (oligo) delivery. Polycations having linear, branched, dendritic. block- or graft copolymer architectures are used in these studies. All these molecules bind to nucleic acids due to formation of cooperative systems of salt bonds between the cationic groups of the polycation and phosphate groups of the DNA. To improve solubility of the DNA/polycation complexes, cationic block and graft copolymers containing segments from polycations and non-ionic soluble polymers, for example, poly(ethylene oxide) (PEO) were developed. Binding of these copolymers with short DNA chains, such as oligos, results in formation of species containing hydrophobic sites from neutralized DNA polycation complex and hydrophilic sites from PEO. These species spontaneously associate into polyion complex micelles with a hydrophobic core from neutralized polyions and a hydrophilic shell from PEO. Such complexes are very small (10-40 nm) and stable in solution despite complete neutralization of charge. They reveal significant activity with oligos in vitro and in vivo. Binding of cationic copolymers to plasmid DNA forms larger (70-200 nm) complexes. which are practically inactive in cell transfection studies. It is likely that PEO prevents binding of these complexes with the cell membranes ("stealth effect"). However attaching specific ligands to the PEO-corona can produce complexes, which are both stable in solution and bind to target cells. The most efficient complexes were obtained when PEO in the cationic copolymer was replaced with membrane-active PEO-b-poly(propylene oxide)-b-PEO molecules (Pluronic 123). Such complexes exhibited elevated levels of transgene expression in liver following systemic administration in mice. To increase stability of the complexes, NanoGel carriers were developed that represent small hydrogel particles synthesized by cross-linking of PEI with double end activated PEO using an emulsification/solvent evaporation technique. Oligos are immobilized by mixing with NanoGel suspension, which results in the formation of small particles (80 nm). Oligos incorporated in NanoGel are able to reach targets within the cell and suppress gene expression in a sequence-specific fashion. Further. loaded NanoGel particles cross-polarized monolayers of intestinal cells (Caco-2) suggesting potential usefulness of these systems for oral administration of oligos. In conclusion the approaches using polycations for gene delivery for the design of gene transfer complexes that exhibit a very broad range of physicochemical and biological properties, which is essential for design of a new generation of more effective non-viral gene delivery systems.

A Macrophage−Nanozyme Delivery System for Parkinson's Disease

“…The +/-charge ratio (Z) was calculated by dividing the amount of amino groups of PEI-PEG protonated at pH 7.4 (66) by the total amount of Gln and Asp in catalase. A combination of physicochemical methods (electrophoretic retention, dynamic light scattering (DLS), and transmission electron microscopy (TEM)) was used to characterize composition, size, dispersion stability, morphology, shape, and structure of the obtained nanoparticles, as described previously (69)(70)(71)(72).…”

Poloxamer 188 enhances apoptosis in a human leukemia cell line

“…These drugs also affect proteins or nucleic acids that are present in normal as well as malignant tissues. Targeted therapy (23,24) using pluronic F68 as a carrier may be more effective than current treatments and less harmful to normal cells. Pluronic F68 appears to possess unique drug-targeted cancer cell interactions in the K5262 cell line.…”

Nanomedicine in the diagnosis and therapy of neurodegenerative disorders

“…Nanoparticles can be used for drug and gene delivery [21,30,31,33,140,142,[185][186][187][188][189][190][191][192][193][194]. They are often composed of insoluble polymer(s).…”

“…Such networks swell in water and can incorporate through ionic interactions of oppositely charged molecules such as oligonucleotides, siRNA, DNA, proteins and low molecular mass drugs. Their loading proceeds with very high capacities (up to 40-60% wt) not achieved with conventional nanoparticles [140,191,237,238,[240][241][242]. Because of solubility of PEG chains, individual collapsed nanogel particles do not phase separate and form stable dispersions.…”